Change over period: —
NSE · JLHL
JLHL
-12.9% from the 52-week high · +20.8% above the low
Jupiter Life Line Hospitals Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Thane, Maharashtra. The company went IPO on 2023-09-18. Jupiter Life Line Hospitals Limited is an India-based holding company. The firm is engaged in providing services in the field of healthcare and related services. The firm has a total bed capacity of approximately 1,194 hospital beds across three hospitals. The firm operates three hospitals under the Jupiter brand in Thane, Pune, and Indore, with an operational bed capacity (census and non-census beds) of 950 beds and 900 beds, and over 1,246 doctors, including specialists, physicians, and surgeons. The company is also focused on developing a multi-specialty hospital in Dombivli, Maharashtra. The Company’s subsidiaries include Jupiter Hospitals Projects Private Limited and Medulla Healthcare Private Limited.
The short version. JLHL reported revenue of ₹456 crore for Sep 2026, up 15.7% from a year earlier. Net profit was ₹56 crore (down 1.8% year on year). Return on equity was 12.9% in Mar 2026. Promoter holding was 40.91% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
JLHL trades 12.9% below its 52-week high and 20.8% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹456 cr.
Sep 2026 net profit of ₹56 cr.
2.3 pts lower than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 456 | 411 | 388 | 365 | 394 | 348 | 327 | 321 |
| Net profit | 56 | 37 | 49 | 43 | 57 | 44 | 45 | 53 |
| Net margin % | 12.3 | 9.1 | 12.6 | 11.6 | 14.6 | 12.6 | 13.7 | 16.4 |
| EPS (₹) | 1.71 | 1.14 | 1.49 | 1.3 | 1.75 | 1.34 | 1.37 | 1.6 |
Annual
| FY2026 | FY2025 | FY2024 | |
|---|---|---|---|
| Revenue | 1500 | 1262 | 1070 |
| Net profit | 199 | 193 | 177 |
| Net margin % | 13.3 | 15.3 | 16.5 |
| EPS (₹) | 6.07 | 5.89 | 5.39 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 12.9% in Mar 2026; debt to equity is 0.33.
Profitability · 3 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Return on equity % | 12.9 | 14.2 | 15.1 |
| Return on capital % | 13.8 | 15.3 | 18.9 |
| EBITDA margin % | 25.0 | 25.2 | 24.1 |
| Net margin % | 12.9 | 15.0 | 16.1 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Down 0.91 pts over 8 quarters.
Up 3.39 pts over 8 quarters.
+12 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 40.91 | 40.91 | 40.91 | 40.91 | 40.91 | 40.91 | 40.91 | 40.91 | 0.0 |
| FII | 10.04 | 10.03 | 9.77 | 9.06 | 8.48 | 8.48 | 9.37 | 9.13 | -0.91 |
| DII | 15.74 | 15.63 | 15.82 | 16.95 | 17.43 | 17.01 | 16.51 | 19.13 | +3.39 |
| Public | 33.3 | 33.42 | 33.5 | 33.08 | 33.17 | 33.6 | 33.21 | 30.83 | -2.47 |
Mutual fund holdings · Oct 2026
33 schemes hold this stock
21 the month before.
- ICICI Prudential Life Cycle Fund 20362.69% of NAV
- Groww BSE Hospitals ETF2.25% of NAV
- UTI - Healthcare Fund2.24% of NAV
- SBI MultiCap Fund2.18% of NAV
- SBI Healthcare Opportunities Fund2.12% of NAV
- ICICI Prudential Life Cycle Fund 20411.96% of NAV
- THE WEALTH COMPANY SMALL CAP FUND1.91% of NAV
- HDFC Consumption Fund1.72% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for JLHL are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about JLHL
What is the JLHL share price?
JLHL (JLHL) last closed at ₹280.80, down 3.04% on the day. Its 52-week range is ₹239.65 to ₹332.40.
What is the market cap of JLHL?
JLHL has a market capitalisation of about ₹9,494 crore. Its price-to-earnings ratio is 51.0.
How are JLHL's latest results?
JLHL reported revenue of ₹456 crore for Sep 2026, up 15.7% from a year earlier. Net profit was ₹56 crore (down 1.8% year on year). Return on equity was 12.9% in Mar 2026. Promoter holding was 40.91% in Sep 2026, up 0.00 points over 8 quarters.
Who owns JLHL?
As of Sep 2026, shareholding was: Promoter 40.91%, FII 9.13%, DII 19.13%, Public 30.83%.
How many mutual funds hold JLHL?
33 mutual fund schemes held JLHL in October 2026. That compares with 21 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 22 May 2026 · Interim Dividend - Rs. 1
- 04 Jul 2025 · Final Dividend - Rs. 1
- 02 Aug 2024 · Final Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.